Yun

Foundation date

30/12/2014

Sector

#Biotechnology - other

Subsector

YUN NV focuses on proven and effective solutions to maintain, strengthen and restore your skin flora. YUN is a privately owned European biotech company that carries out groundbreaking research and develops probiotherapy.
YUN Probiotherapy is able to offer an effective and sustainable solution for common skin conditions and reduce the excessive use of antibiotics and antimycotics.

Upcoming events

Latest news

  • argenx reports topline results from ADVANCE-SC study of VYVGART Hytrulo in primary immune thrombocytopenia

    21 hours ago

  • Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansion

    Wednesday November 22nd 2023

  • argenx announces European Commission approval of subcutaneous VYVGART® (efgartigimod alfa) for generalized myasthenia gravis

    Thursday November 16th 2023